Fei Pan
Vermogen: 66 M $ op 31-05-2026
Vermogen: 66 M $ op 31-05-2026
Fei Pan is currently Chief Executive Officer & Executive Director at Jenscare Scientific Co., Ltd., a position starting in 2026.
Formerly, Mr. Pan was a Portfolio Manager at China International Capital Corp.
Ltd. (Invt Management).
Education includes a graduate degree from the University of Cambridge in 2010, a graduate degree from the University of Warwick in 2009, and an undergraduate degree from the University of Lancaster in 2008.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-05-2025 | 63.544.279 ( 20,48% ) | 66 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| JENSCARE SCIENTIFIC CO., LTD. | Algemeen Directeur | 15-01-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
China International Capital Corp. Ltd. (Invt Management)
China International Capital Corp. Ltd. (Invt Management) Investment ManagersFinance CICC-IM aims to deliver excellent, long-term performance through their proven investment process, established risk management framework and strong research capability. | Portefeuillebeheerder-Aandelen | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Lancaster
University of Lancaster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warwick
University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China International Capital Corp. Ltd. (Invt Management)
China International Capital Corp. Ltd. (Invt Management) Investment ManagersFinance CICC-IM aims to deliver excellent, long-term performance through their proven investment process, established risk management framework and strong research capability. | Finance |
Jenscare Scientific Co. Ltd.
Jenscare Scientific Co. Ltd. Medical SpecialtiesHealth Technology Develops and sells transcatheter aortic valve systems | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau